Helius Medical Technologies, Inc. (HSDT)
Stock Price:
$0.449 USD
-0.013 (-2.71%)
Updated Oct 21, 2020 4:00 PM EDT - Market closed
After-hours: $0.461 +0.011 (2.49%) Oct 21, 7:50 PM
Key Info
| Market Cap |
20.27M |
| Revenue (ttm) |
642,000 |
| Net Income (ttm) |
-19.04M |
| Shares Out |
45.11M |
| EPS (ttm) |
-0.60 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Oct 21, 2020 |
| Last Price |
$0.449 |
| Previous Close |
$0.462 |
| Change ($) |
-0.013 |
| Change (%) |
-2.71% |
| Day's Open |
0.470 |
| Day's Range |
0.440 - 0.470 |
| Day's Volume |
135,964 |
| 52-Week Range |
0.249 - 1.690 |
More Stats
| Market Cap |
20.27M |
| Enterprise Value |
15.22M |
| Earnings Date (est) |
Nov 5, 2020 |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
45.11M |
| Float |
36.13M |
| EPS (basic) |
-0.65 |
| EPS (diluted) |
-0.60 |
| FCF / Share |
-0.42 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
960,702 |
| Short Ratio |
5.41 |
| Short % of Float |
2.66% |
| Beta |
0.75 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
31.57 |
| PB Ratio |
3.03 |
| Revenue |
642,000 |
| Operating Income |
-19.09M |
| Net Income |
-19.04M |
| Free Cash Flow |
-16.86M |
| Net Cash |
5.05M |
| Net Cash / Share |
0.11 |
| Gross Margin |
101.56% |
| Operating Margin |
-2,972.74% |
| Profit Margin |
-2,965.30% |
| FCF Margin |
-2,626.48% |
| ROA |
-87.38% |
| ROE |
-198.53% |
| ROIC |
-4,056.90% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (1)
| Buy |
0 |
| Overweight |
0 |
| Hold |
1 |
| Underweight |
0 |
| Sell |
0 |
Low
10.0
Current: $0.449
High
10.0
Target: 10.00
*Average 12-month price target from 1 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2015 | 2014 | 2013 |
|---|
| Revenue | 1.50 | 0.48 | - | - | - | - |
| Revenue Growth | 212.97% | - | - | - | - | - |
| Gross Profit | 0.65 | 0.48 | - | - | - | - |
| Operating Income | -24.00 | -26.68 | -22.85 | -9.32 | -9.81 | -1.07 |
| Net Income | -9.78 | -28.62 | -28.02 | -6.88 | -9.84 | -1.07 |
| Shares Outstanding | 26.35 | 22.79 | 18.63 | 13.30 | 11.41 | 6.41 |
| Earnings Per Share | -0.37 | -1.26 | -1.50 | -0.60 | -0.85 | -0.15 |
| Operating Cash Flow | -21.00 | -19.62 | -19.33 | -7.94 | -6.32 | -0.35 |
| Capital Expenditures | -0.35 | -0.44 | -0.19 | - | - | - |
| Free Cash Flow | -21.35 | -20.06 | -19.52 | -7.94 | -6.32 | -0.35 |
| Cash & Equivalents | 5.46 | 25.58 | 5.56 | 2.64 | 0.80 | 0.02 |
| Total Debt | 0.64 | - | - | - | - | 0.37 |
| Net Cash / Debt | 4.82 | 25.58 | 5.56 | 2.64 | 0.80 | -0.35 |
| Assets | 10.35 | 27.83 | 6.81 | 4.04 | 1.22 | 0.32 |
| Liabilities | 4.51 | 17.97 | 14.30 | 4.06 | 2.78 | 0.58 |
| Book Value | 5.84 | 9.85 | -7.49 | -0.02 | -1.56 | -0.27 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Helius Medical Technologies, Inc. |
| Country |
United States |
| Employees |
19 |
| CEO |
Dane Carl Andreeff |
Stock Information
| Ticker Symbol |
HSDT |
| Stock Exchange |
NASDAQ |
| Sector |
Healthcare |
| Industry |
Medical Devices |
| Unique Identifier |
NASDAQ: HSDT |
Description
Helius Medical Technologies, a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator (PoNS), a medical device in Canada for the treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury. Its PoNS device treats neurostimulation of cranial nerves via the tongue to restore lost function. The company is headquartered in Newtown, Pennsylvania.